You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 8,426,392


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,426,392 protect, and when does it expire?

Patent 8,426,392 protects ELLA and is included in one NDA.

This patent has one patent family member in one country.

Summary for Patent: 8,426,392
Title:Method for providing emergency contraception
Abstract: The invention provides a method for providing emergency contraception in a female subject, comprising providing the subject with a therapeutically effective amount of ulipristal acetate in an oral dosage form before, during or after a meal. The invention further provides a kit comprising i) an oral dosage form comprising ulipristal acetate and ii) a printed matter stating that ulipristal acetate may be taken with or without food.
Inventor(s): Gainer; Erin (Paris, FR), Mathe; Henri Camille (Paris, FR)
Assignee: Laboratoire HRA-Pharma (Paris, FR)
Application Number:12/633,885
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,426,392
Patent Claim Types:
see list of patent claims
Use; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,426,392: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 8,426,392, exploring its claims, the patent landscape, and the implications of its existence.

What is United States Patent 8,426,392?

To begin, it is essential to identify the subject matter of the patent. However, since the specific details of this patent are not provided in the sources, we will use general principles to analyze its scope and claims.

Understanding Patent Claims

Patent claims are the heart of any patent, defining the scope of protection granted to the inventor. These claims must be clear, concise, and definite to avoid ambiguity and potential legal disputes[4].

Types of Claims

  • Independent Claims: These stand alone and define the invention without reference to other claims.
  • Dependent Claims: These refer back to and further limit an independent claim.
  • Method Claims: Describe a process or method.
  • Apparatus Claims: Describe a device or system.

Analyzing the Scope of Patent 8,426,392

Claim Construction

The scope of a patent is determined by the construction of its claims. This involves interpreting the language used in the claims to understand what is covered and what is not. The courts often use a two-step process: first, determining the ordinary and customary meaning of the claim terms, and second, considering the context in which the terms are used, including the specification and the prosecution history[2].

Claim Limitations

Each claim will have specific limitations that define the boundaries of the invention. These limitations can include structural elements, functional aspects, or specific methods. For example, if the patent is related to a medical device, the claims might specify particular materials, dimensions, or operational steps.

Patent Landscape Analysis

What is Patent Landscape Analysis?

Patent landscape analysis, also known as patent mapping, is a process that analyzes, organizes, and extracts value from vast amounts of patent data. This analysis helps in understanding the entire landscape of a technology domain and provides valuable insights into competitors and market trends[3].

Key Elements of Patent Landscape Analysis

  • Application Number, Filing Date, and Country: These details help identify the patent and its status across different jurisdictions.
  • Legal Status: This includes whether the patent is alive, pending, lapsed, revoked, or expired.
  • Expected Expiry Dates: Knowing when patents are expected to expire is crucial for strategic planning.
  • Market Developments: This includes mergers and acquisitions, in/out-licensing, litigation, and opposition activities.

Applying Patent Landscape Analysis to Patent 8,426,392

To analyze the landscape around Patent 8,426,392, one would need to identify similar patents in the same technological domain. This involves searching databases such as the USPTO, European Patent Office's Espacenet, and Google Patents. The analysis would reveal:

  • Competitors: Who else is working in this field and what are their patent portfolios?
  • Market Trends: Are there emerging technologies or shifts in the market that could impact the patent's value?
  • Litigation and Opposition: Are there any ongoing legal challenges or oppositions that could affect the patent's validity?

Searching and Accessing Patent Information

USPTO and Other Databases

The USPTO provides several tools for searching patent grants and applications, including the Patent Public Search database and the Cooperative Patent Classification (CPC) database. Other resources like the European Patent Office's Espacenet and Google Patents offer comprehensive access to international patent data[4].

Historical Patents

For historical context, resources like the New York Public Library's guides on historical U.S. patents can be invaluable. These guides provide access to early patents, including those issued from 1790 to 1836, which can offer insights into the evolution of technologies[1].

Legal Implications and Challenges

Doctrine of Double Patenting

The doctrine of double patenting prohibits the issuance of multiple patents for the same invention. This can be a critical issue if there are related patents with overlapping claims. For example, in the case of Allergan USA, Inc. v. MSN Laboratories Private Ltd., the court determined that a first-filed, first-issued patent could not be invalidated by later-filed, later-issued patents with the same priority date[2].

Patent Term and Expiry

Understanding the patent term and expiry dates is essential for strategic planning. The Uruguay Round Agreements Act of 1994 changed how patent terms are calculated, now measuring from the effective filing or priority date rather than the issuance date[2].

Strategic Decision-Making

Identifying Opportunities and Risks

Patent landscape analysis helps in identifying opportunities such as potential licensing agreements or acquisitions. It also highlights risks such as litigation or opposition activities that could threaten the patent's validity.

Market Development Insights

The analysis provides insights into market developments, such as mergers and acquisitions, which can influence the competitive landscape and the value of the patent.

Key Takeaways

  • Clear Claim Construction: The scope of a patent is defined by its claims, which must be clear and concise.
  • Patent Landscape Analysis: This analysis is crucial for understanding the competitive landscape and market trends.
  • Legal Implications: Understanding doctrines like double patenting and patent term calculations is vital for strategic decision-making.
  • Access to Information: Utilizing databases like the USPTO and Espacenet is essential for comprehensive patent searches.

FAQs

Q: What are the key elements of patent claims? A: Patent claims include independent and dependent claims, method claims, and apparatus claims, each defining different aspects of the invention.

Q: How is patent landscape analysis conducted? A: Patent landscape analysis involves using computer tools and human intelligence to analyze, organize, and extract value from vast amounts of patent data, providing insights into competitors, market trends, and legal status.

Q: Where can I find historical U.S. patents? A: Historical U.S. patents can be found through resources like the New York Public Library's guides, which provide access to patents issued from 1790 onwards.

Q: What is the doctrine of double patenting? A: The doctrine of double patenting prohibits the issuance of multiple patents for the same invention, ensuring that an inventor cannot obtain multiple patents for a single invention.

Q: How are patent terms calculated? A: Patent terms are now calculated from the effective filing or priority date rather than the issuance date, following the Uruguay Round Agreements Act of 1994.

Sources

  1. NYPL Libguides: How to Search for an Historical U.S. Patent.
  2. CAFC: Allergan USA, Inc. v. MSN Laboratories Private Ltd.
  3. Sagacious Research: Navigating Technological Domains with Patent Landscape Analysis.
  4. Clemson Libguides: Advanced Patent Searching.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,426,392

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Lab Hra Pharma ELLA ulipristal acetate TABLET;ORAL 022474-001 Aug 13, 2010 AB RX Yes Yes 8,426,392 ⤷  Subscribe ELLA IS A PROGESTERONE AGONIST/ANTAGONIST EMERGENCY CONTRACEPTION INDICATED FOR THE PREVENTION OF PREGNANCY FOLLOWING UNPROTECTED INTERCOURSE OR A KNOWN OR SUSPECTED CONTRACEPTIVE FAILURE. ELLA CAN BE TAKEN WITH OR WITHOUT FOOD ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,426,392

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
World Intellectual Property Organization (WIPO) 2011069871 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.